/Companies

Diantpharma

Manchester, US · Founded 2019

Find your way into Diantpharma

Sign up to find every way you can get introduced to Diantpharma

  • Your email: who you already know at Diantpharma, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Diantpharma team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

DIANT develops proprietary Jet technology and continuous, closed manufacturing systems for producing nanoparticles and lipid nanoparticles (LNPs), and offers R&D through manufacturing services. Its systems serve customers making nanoparticle products for pharmaceuticals, nutraceuticals, food, beverage, and cosmetics.

Founders & leadership

Diantpharma was founded in 2019 by Diane Burgess and Antonio Costa.

DB
Diane BurgessCo-founder
ACAntonio Costa
Antonio CostaCo-founder · Chief Executive Officer/ ChairmanExecutive Officer, Director at DIANT® Pharma Inc.

Reported raises · per SEC filings

Form D private placements

$1.4M disclosed across 1 round · 2022

▶$1.4MraisedSep 2022 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Diane BurgessExecutive Officer, Director
  • Antonio CostaExecutive Officer, Director
Offering amount
$4.8M
Amount sold
$1.4M
First sale
Sep 2022
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Science FoundationPhase I2022$256K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Diantpharma do?
DIANT develops proprietary Jet technology and continuous, closed manufacturing systems for producing nanoparticles and lipid nanoparticles (LNPs), and offers R&D through manufacturing services. Its systems serve customers making nanoparticle products for pharmaceuticals, nutraceuticals, food, beverage, and cosmetics.
Who founded Diantpharma?
Diantpharma was founded by Diane Burgess, Antonio Costa in 2019.
How much funding has Diantpharma raised?
Diantpharma has disclosed $1.4M raised across 1 round.
Where is Diantpharma headquartered?
Diantpharma is headquartered in Manchester, US.